We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

148 hedge funds and large institutions have $1.32B invested in Acorda Therapeutics in 2013 Q2 according to their latest regulatory filings, with 148 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

475% more call options, than puts

Call options by funds: $14.7M | Put options by funds: $2.56M

Holders
148
Holders Change
+148
Holders Change %
–
% of All Funds
4.83%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
148
Increased
–
Reduced
–
Closed
–
Calls
$14.7M
Puts
$2.56M
Net Calls
+$12.2M
Net Calls Change
+$12.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
101
Jane Street
New York
$569K +$593K +144 New
PPA
102
Parametric Portfolio Associates
Washington
$561K +$585K +142 New
Capital Fund Management (CFM)
103
Capital Fund Management (CFM)
France
$516K +$535K +130 New
Public Employees Retirement Association of Colorado
104
Public Employees Retirement Association of Colorado
Colorado
$514K +$535K +130 New
NTCOC
105
Northern Trust Company of Connecticut
Connecticut
$508K +$527K +128 New
VAM
106
Visium Asset Management
New York
$506K +$527K +128 New
BNP Paribas Financial Markets
107
BNP Paribas Financial Markets
France
$468K +$486K +118 New
GCP
108
GSA Capital Partners
United Kingdom
$444K +$461K +112 New
PCM
109
Prelude Capital Management
New York
$434K +$453K +110 New
First Trust Advisors
110
First Trust Advisors
Illinois
$427K +$445K +108 New
IG
111
ING Group
Netherlands
$397K +$412K +100 New
ZCM
112
Zebra Capital Management
Connecticut
$397K +$412K +100 New
Bank of Montreal
113
Bank of Montreal
Ontario, Canada
$383K +$399K +97 New
USAA
114
United Services Automobile Association
Texas
$373K +$387K +94 New
HCM
115
Highbridge Capital Management
New York
$310K +$321K +78 New
Federated Hermes
116
Federated Hermes
Pennsylvania
$299K +$313K +76 New
HI
117
HBK Investments
Texas
$267K +$280K +68 New
AI
118
Analytic Investors
California
$255K +$264K +64 New
Tudor Investment Corp
119
Tudor Investment Corp
Connecticut
$244K +$255K +62 New
QBFM
120
QS Batterymarch Financial Management
New York
$235K +$243K +59 New
Massachusetts Financial Services
121
Massachusetts Financial Services
Massachusetts
$234K +$243K +59 New
TD Asset Management
122
TD Asset Management
Ontario, Canada
$234K +$243K +59 New
FMT
123
First Mercantile Trust
Tennessee
$217K +$226K +55 New
Allianz Asset Management
124
Allianz Asset Management
Germany
$214K +$222K +54 New
MCM
125
Manchester Capital Management
Vermont
$212K +$222K +54 New
2 3 4
5
6

ACOR Hedge Fund Activity: Q2 2013 in Review

148 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q2 2013, worth a combined $1.32B.

Buyers outnumbered sellers: 148 funds opened new ACOR positions and 0 closed out — a net gain of 148 holders — while 0 added to existing stakes and 0 trimmed.

  • 148 institutional investors held Acorda Therapeutics (ACOR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.32B of Acorda Therapeutics stock for Q2 2013.
  • 148 funds opened new Acorda Therapeutics positions in Q2 2013 and 0 closed out, a net change of +148 holders.

Based on aggregated 13F filings for Q2 2013.